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Long-term Outcome after Bare-Metal or Drug-Eluting Stenting for
Allograft Coronary Artery Disease
Farzin Beygui, Shaida Varnous, Gilles Montalescot, Flor Fernandez, Jean-
Philippe Collet, Pascal Leprince, Claude Lefeuvre, Alain Pavie, Jean-Phi-
lippe Metzger, Iradj Gandjbakhch
Groupe hospitalier pitié salpêtrière, cardiologie, Paris, France
Percutaneous coronary intervention (PCI) with BMS has been reported to
be associated with poor outcome in heart transplant recipient. We aimed to
assess the outcome of successful PCI with bare-metal stents (BMS) or drug-
eluting stents (DES) in heart transplant recipients.
Methods: Ninety-four consecutive heart transplant recipients with suc-
cessful PCI of de novo lesions with BMS (n=53) or DES (n=60) were prospec-
tively followed-up for 41.8±31.5 months after the PCI.
Results: The lesion-based analysis within 12 months after PCI showed a
marked reduction of target lesion revascularization (TLR) and restenosis rates
by the use of DES (6.9% versus 26.4%, p=0.005 and 7.1% versus 32.1%,
p=0.001 respectively). The patient-based multivariable analysis identified
transplantation to PCI time (HR 1.1 per month), absence of antihypertensive
therapy (HR 4.53) and left ventricular ejection fraction (HR 0.95 per percent)
but not stent type as independent correlates of death. BMS (HR 3.79) and tac-
rolimus use (HR 8.32) were independent correlates of TLR.
Conclusions: Compared to BMS, DES are associated with a marked reduc-
tion in rates of restenosis and TLR in heart transplant recipients and may be
recommended despite the absence of a relationship between the stent type and
survival. Early treatment of allograft vasculopathy, extensive antihypertensive
therapy and left ventricular function preservation, appear as major goals of
treatment to improve long-term survival in such patients. 
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A standardized approach of aortic valve sparing combining root remo-
deling and aortic annuloplasty: impact of additional cusp repair?
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Eric Arnaud Crozat (7), Stéphane Lopez (8), Francis Baud (4), Christophe
Acar (9), Thierry Folliguet (10), Mathieu Debauchez (1)
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(2) Centre Hospitalier Intercommunal Le Raincy Montfermeil, Chirurgie
Vasculaire, Montfermeil, France – (3) CHU Michallon, Grenoble, France –
(4) Clinique Saint Gatien, Tours, France – (5) CHU Bocage, Dijon,
France – (6) Clinique Saint Augustin, Bordeaux, France – (7) Clinique
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Objectives: Aortic valve sparing is gaining increasing acceptance, however
association with cusp repair may jeopardize its results. We studied patients
operated electively with a standardized valve sparing approach with or without
additional cusp repair.
Methods: 125 patients with aortic root aneurysms underwent the Remod-
eling technique combined with a subvalvular annuloplasty in 10 centers (16
surgeons). Patients were analysed prospectively in 2 groups: without cusp
repair (group 1, n=80) and with cusp repair (group 2, n=45) using plicating
stitches (33), and/or running suture (10), and/or median raphe resection (12).
Results: Despite more severe preoperative aortic insufficiency (AI) in
group 2, reoperation rate was not significantly higher (table). Five over 6 reop-
erations occurred during early experience. Cusp repair rate increased from
22.3% (15) in early period to 53.4% (27, p<0.01) since 2007, when aggressive
management of cusp prolapse was started combining cusp free edges align-
ment with effective height measurement. 
Conclusion: Additional cusp repair does not affect early results of aortic
valve sparing. Standardized management of root remodeling, cusp repair and
aortic annuloplasty may improve feasibility and long term outcomes. This
approach is currently evaluated versus mechanical valve replacement by CAV-
IAAR trial (Conservative Aortic Valve surgery for aortic Insufficiency and
Aneurysms of the Aortic Root).
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Early postoperative results of De Vega tricuspid annuloplasty for tri-
cuspid regurgitation in rheumatic Mitral disease
Abdelkarim Errahmouni (1), Rachid Elhaouatti (2), Mustapha Elhattaoui
(1), Drissi Boumzebra (2)
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Objectives: Tricuspid regurgitation (TR) in patients with mitral valve
(MV) disease is associated with poor outcome and predicts poor survival, heart
failure, and reduced functional capacity.
We review our early results in patients who required surgical correction of
tricuspid valve disease with concomitant rheumatic disease of the mitral valve
operated on between 2005 and 2008.
Methods: We studied 68 consecutive patients (mean age, 32 years). All
patients were investigated perioperatively by Doppler echocardiography.
Echocardiographic assessment of tricuspid incompetence was on the basis of
gradation of tricuspid regurgitation severity according to color Doppler flow
criteria, the flow convergence region proximal to the regurgitant orifice
(PISA), the size of the tricuspid annulus, and estimation of the pulmonary
artery systolic pressure by continuous Doppler. Median tricuspid insufficiency
was 3+. Tricuspid lesions were functional in 59 patients and organic in 9
patients. The cause was rheumatic mitral valve disease in all patients. Any
patient has an aortic surgical dlession. All patients underwent De Vega tri-
cuspid annuloplasty at the time of mitral surgery.
Results: There was one operative death. Prosthetic mitral replacement was
performed in 57 patients (83.82%) and a mitral valve repair in 11 patients
(16.17%). There was 1+ or less TR in 59 patients (86.7%), moderate TR 2+ in
7 patients (10.2%) and severe TR 3+ in two patients how had a severe pulmo-
nary hypertension.
January 15th, Friday 2010
January 16th, Saturday 2010
 Group 1
without 
cusp repair
Group 2
 with 
cusp repair
Marfan 16 (20%) 2 (4.4%)*
Bicuspid valves 7 (8.8%) 19 (42.2%)*
Preoperative AI grade 1.66±1.2 (0-4) 2.42±1.2 (0-4)* 
Preoperative annulus diameter (mm) 27.5±1.6 (23-30) 28.6±2.1 (24-36)*
Operative mortality 4 (5%) 1 (2.2%)
Postoperative annulus diameter (mm) 20.1±2.1 (17-25) 21.3±1.1 (16-25)*
Post-operative AI grade 0.3±0.4 (0-1) 0.2±0.4 (0-1)
Mean follow-up (months) 36.1±21 (1-69) 17.5±16.9 (1-66)*
Freedom from AI≥grade 2 64 (94.1%) 37 (92.5%)
Reoperation for valve replacement 4 (5%) 2 (4.4%)
Survival 72 (97.3%) 42 (95.5%)
*p<0.05
